Skip to Content

Morgan Stanley raises its price target on MetLife (NYSE:MET) to $88.00.

Morgan Stanley raises its price target on MetLife (NYSE:MET) to $88.00.

According to Benzinga, equity analysts at Morgan Stanley raised their price objective for MetLife (NYSE: MET) in a report issued on Tuesday. The price objective increased from $87.00 to $88.00. The brokerage firm is now giving an “overweight” rating to the company’s stock because of the company’s involvement in the financial services industry. The price target established by Morgan Stanley could increase the price of the stock, which is 23.35 percent higher than the current price.

Over the past few months, MET has emerged as the subject of interest from various research companies. In a report made public on Monday, Goldman Sachs Group lowered their price target for MetLife from $80.00 to $78.00 and changed the company’s rating from “buy” to “neutral.” MetLife’s share price was given an “overweight” rating by JPMorgan Chase & Co. in a research note released on Friday. The firm raised its target price for MetLife from $77.00 to $80.00 and its price target for the stock from $77.00 to $80.00. On October 12, a Wednesday, StockNews.com began providing research coverage for MetLife as part of their offerings. They recommended that shareholders “hold” their shares of the company. Citigroup stated that they would be increasing their price target for MetLife shares from $70.00 to $80.00 and publishing their findings in a research study released on November 16. Raymond James announced that it would begin covering MetLife shares in a research note published on September 21, a Wednesday. They gave the stock a rating of “market perform” for its performance. Ten analysts have given the company a recommendation to buy, while only four have recommended that investors hold onto their shares. According to Bloomberg.com, the stock is presently assigned a consensus rating of “Moderate Buy,” The price target has been set at an average of $79.17.

When trading started on Tuesday, a MetLife stock went for $71.34 per share. The company’s stock has a price-to-earnings ratio of 26.82, a price-to-earnings-growth ratio of 4.99, and a beta of 1.07. The company’s shares are currently trading at a market value of $55.97 billion. There is a ratio of 0.60 debt to equity, 0.14 for the current ratio, and 0.14 for the quick ratio. Each of these ratios is also equal to 0.14. The moving average of the company’s stock price over the past 50 days is $73.84, and the moving average over the last 200 days is $67.83. Over a single year, MetLife’s stock price ranged from an all-time low of $57.41 to an all-time high of $77.36.

On November 2, the results of MetLife’s most recent quarterly report on earnings were made public. MetLife trades under the ticker symbol NYSE: MET. The company that provides financial services reported earnings per share for the quarter of $1.21, which was $0.03 higher than the consensus estimate of $1.18. In addition, the company’s quarterly sales came in at $23.69 billion, which is considerably higher than the industry analysts’ prediction of $19.89 billion, which the company surpassed by a wide margin. During the year, MetLife achieved a return on equity of 13.60% and a net margin of 3.26%. Sell-side analysts projected that MetLife would generate $7.08 in earnings per share for the current fiscal year.

According to some additional MetLife-related information, Bill Pappas, Executive Vice President of MetLife, sold 5,000 shares of the company’s stock on December 7. It was determined that the stock was sold for $75.55 per share, which resulted in a total sale volume of $377,750.00. This was determined based on the average price of the stock. The transaction has directly resulted in the executive vice president gaining ownership of 65,147 shares. Based on the current market price, these shares are worth $4,921,855.85. The sale of the company’s stock took place on December 7, and it was made public through a filing with the SEC, which can be found on the SEC’s website information. It was determined that the stock was sold for $75.55 per share, which resulted in a total sale volume of $377,750.00. This was determined based on the average price of the stock. The transaction has directly resulted in the executive vice president gaining ownership of 65,147 shares. Based on the current market price, these shares are worth $4,921,855.85. The sale of the company’s stock took place on December 7 and was made public through a filing with the SEC, which can be found on the SEC’s website. It was determined that the stock was sold for $75.55 per share, which resulted in a total sale volume of $377,750.00. This was determined based on the average price of the stock. The transaction has directly resulted in the executive vice president gaining ownership of 65,147 shares. Based on the current market price, these shares are worth $4,921,855.85. The transaction was made public through a filing that was made with the SEC, which can be located on the website of the SEC. On Monday, December 12, Executive Vice President Steven J. Goulart sold 29,401 shares of the company’s stock, which is another noteworthy occurrence to bring to your attention. During the sale, each share was acquired for an average price of $71.88. This resulted in the total value of the transaction being $2,113,343.88. Following the completion of the sale, the executive vice president will have a total of 273,310 company shares, each of which is approximately worth $19,645,522.80. The transaction was described in a document distributed by the SEC and can be viewed on the organization’s website. In addition, on December 7, Bill Pappas, Executive Vice President of the company, sold 5,000 shares of the company’s stock. It was determined that the shares were sold at an average price of $75.55 each, which resulted in a total sale volume of $377,750.00. The price at which each share was sold was determined to be $75.55. Because of the sale, the executive vice president has direct control over 65,147 shares of company stock. The total value of these shares is $4,921,855.85; Disclosures related to the sale might be found in this website section. Insiders of the company have sold 37,401 shares of company stock over the course of the past 90 days, resulting in total revenue of $2,706,824. The company’s management and employees have a combined control of 0.26 percent of the company’s total outstanding shares.

In recent months, the number of institutional investors and hedge funds has either increased or decreased the number of MET shares in their portfolios. DURING THE THIRD QUARTER, Price T. Rowe Associates Inc. (MD) made a 41.1% increase in the proportion of its holdings in MetLife that the company owned. Price T. Rowe Associates Inc. (MD) now has a total of 20,165,769 shares of the financial services provider’s stock, valued at $1,225,676,000, after purchasing an additional 5,876,930 shares throughout the previous period. This brings the company’s total number of shares to 20,165,769; during the third quarter, the investment portfolio managed by Nuveen Asset Management, LLC, added 9.5% more MetLife shares than it had previously. Nuveen Asset Management LLC now has a total of 6,714,845 shares of the financial services provider’s stock due to the purchase of an additional 582,095 shares during the relevant period. The stock currently has a value of $408,128,000, and Nuveen Asset Management LLC’s holdings are worth that amount. During the third quarter, Barclays PLC achieved a 92.5% increase in the proportion of MetLife stock it owned. Barclays PLC increased its stake in the company by purchasing an additional 2,530,149 shares during the most recent quarter, bringing its total number of shares held in the company to 5,264,670. This results in a market value of $319,989,000 for the company. During the second quarter, Legal & General Group Plc increased the amount of MetLife stock owned by 0.5 percent, bringing the total to 100 percent. After purchasing an additional 24,121 shares throughout the period in question, Legal & General Group Plc has a total stock holding value of $5,234,652 for the financial services business. And finally, but certainly not least, during the second quarter of this year, Clearbridge Investments LLC increased the percentage of MetLife shares it owned by 0.4%. Clearbridge Investments LLC now has 4,744,940 shares held by the financial services provider following the acquisition of an additional 19,197 shares during the most recent quarter. This gives Clearbridge Investments LLC a combined value of $297,935,000 for its stock holdings. 88.15 various institutional investors, including hedge funds, own a percent of the company’s shares.

MetLife, Inc. is a leading global provider of a wide range of financial services in every region. Asset management, annuities, insurance, and employee benefits are some services that fall under this category. The United States of America, Asia, Latin America, Europe, the Middle East, and Africa are the five regions that make up the company’s five divisions. These regions make up the company’s five divisions. In addition to life, dental, group short- and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, the following options are also available:

Prepaid legal plans

Administrative services-only agreements for employers

General and separate accounts

Synthetic guaranteed interest contracts

Private floating rate funding agreements

All of these options are open to consumers. In addition, private floating-rate funding agreements and prepaid legal plans are both made available to customers. Employers also have the option of purchasing prepaid legal plans.

Tags

Leave a comment

Your email address will not be published. Required fields are marked *